Acorda Therapeutics Inc ACORQ:OTCPK

*Data is delayed | Exchange | USD
Last | 05/17/24 EDT
0.605quote price arrow up+0.095 (+18.6275%)
Volume
5,839
52 week range
0.25 - 18.20
Loading...
  • Open0.60
  • Day High0.64
  • Day Low0.59
  • Prev Close0.51
  • 52 Week High18.20
  • 52 Week High Date08/07/23
  • 52 Week Low0.25
  • 52 Week Low Date04/12/24

Key Stats

  • Market Cap751,470.506
  • Shares Out1.24M
  • 10 Day Average Volume0.71M
  • Dividend-
  • Dividend Yield-
  • Beta1.67
  • YTD % Change-95.99

KEY STATS

  • Open0.60
  • Day High0.64
  • Day Low0.59
  • Prev Close0.51
  • 52 Week High18.20
  • 52 Week High Date08/07/23
  • 52 Week Low0.25
  • 52 Week Low Date04/12/24
  • Market Cap751,470.506
  • Shares Out1.24M
  • 10 Day Average Volume0.71M
  • Dividend-
  • Dividend Yield-
  • Beta1.67
  • YTD % Change-95.99

RATIOS/PROFITABILITY

  • EPS (TTM)-212.10
  • P/E (TTM)-0.00
  • Fwd P/E (NTM)-
  • EBITDA (TTM)2.853M
  • ROE (TTM)-23.68%
  • Revenue (TTM)115.664M
  • Gross Margin (TTM)86.38%
  • Net Margin (TTM)-227.75%
  • Debt To Equity (MRQ)-103.07%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Acorda Therapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Acorda Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders. The Company markets Inbrija (levodopa inhalation powder), which is approved in the United States for intermittent treatment of OFF episodes, also known as OFF periods, in people with Parkinson’s disease treated with carbidopa/levodopa. Inbrija is not to be used by patients who take or have taken a...
John Kelley
Non-Executive Independent Chairman of the Board
Ron Cohen M.D.
President, Chief Executive Officer, Director
Michael Gesser
Chief Financial Officer
Neil Belloff Esq., J.D.
General Counsel, Corporate Secretary
Address
TWO BLUE HILL PLAZA
Pearl River, NY
10965
United States

Top Peers

SYMBOLLASTCHG%CHG
SCYX
SCYNEXIS Inc
2.77+0.36+14.94%
AYTU
Aytu Biopharma Inc
2.94-0.02-0.68%
ASRT
Assertio Holdings Inc
1.07+0.05+4.90%
MEIP
MEI Pharma Inc
3.15+0.22+7.51%
RVLPQ
RVL Pharmaceuticals PLC
0.00UNCHUNCH